GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the FLOW question that gets asked weekly, answered properly — 11 comments in the full submission. View in context.
-35
c/trialwatch·submitted 1 year ago by u/adaeze_weiss

the FLOW question that gets asked weekly, answered properly

Readoutbranch of 4 comments

STEP. That is the whole post, but I will justify it. Everything else people worry about in c/orforglipron is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort STEP out first, and almost nobody does. I say this having got it wrong for 14 months. My eGFR was…

Read the full submission and all 11 comments →

This branch

4 comments, started 1 year ago
u/anders_karlsen8 points·1 year ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
u/plateau_patrol2 points·1 year ago

Phase 2 or phase 3?

replysharereportpermalink
u/adaeze_weissOP6 points·1 year ago

Yeah, absolute numbers matter more than the press release.

Disagree on that part. 96.8% and 96.2% on the same vial is normal.

replysharereportpermalink
u/rulebook_rachaelmod · c/meta1 point·1 year ago

Yeah, absolute numbers matter more than the press release.

Disagree on that part. 93.7% and 99.3% on the same vial is normal.

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →